Ketogenic food pyramid for patients with refractory epilepsy: From theory to clinical practice

Autores/as

  • Mariana Baldini PRUDENCIO Universidade de São Paulo
  • Patricia de Azevedo LIMA Universidade de São Paulo
  • Maria Camila Pruper de FREITAS Universidade de São Paulo
  • Flávia de Conti CARTOLANO Universidade de São Paulo
  • Daniela Kawamoto MURAKAMI Universidade de São Paulo
  • Nágila Raquel Teixeira DAMASCENO Universidade de São Paulo

Palabras clave:

Adolescent, Child, Epilepsy, Food and nutrition education, Ketogenic Diet

Resumen

Objective
To develop a graphical representation in the form of a food pyramid for a ketogenic diet for dietary treatment in children and adolescents with refractory epilepsy.

Methods
The pyramid was constructed based on: the estimation of energy requirements for different age groups, macronutrient distribution, food groups, and the number of servings and respective amounts of food according to the ketogenic diet. Serving sizes were based on the calculation of energy and macronutrient requirements according to age and nutritional status.

Results
The pyramid was divided into three tiers and 5 food groups (fats, proteins, type 1 vegetables, type 2 vegetables, and fruits). Four portion size lists were defined for the following age groups: 1-3 years, 4-6 years, 7-10 years, and 11-19 years.

Conclusion
The ketogenic diet food pyramid can be used as nutritional guidance for patients undergoing this dietary therapy by illustrating the variety of foods that can be eaten during the treatment, optimizing adherence to the treatment, and guaranteeing beneficial effects on seizure control.

Citas

Shimada T, Takemyia T, Sugiura H, Yamagata K. The Role of Inflammatory Mediators in the Pathogenesis of Epilepsy. Pediatr Gastroenterol Hepatol Nutr. 2014;15:74-8.

Armeno M, Caraballo R, Vaccarezza M, Alberti MJ, Ríos V, Galicchio S, et al. Consenso nacional sobre dieta cetogénica. Rev Neurol. 2014;59(5):213-23.

Kossoff EH, Wang HS. Dietary therapies for epilepsy. Biomed J. 2013;36(1):2-8.

Kossoff EH, Zupec-Kania BA, Amark PE, BallabanGil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50(2):304-17.

Kim DW, Kang HC, Park jung C, Kim HD. Benefits of the non fasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004;114(6):1627-30.

Lee PR, Kossoff EH. Dietary treatments for epilepsy: Management guidelines for the general practitioner. Epilepsy Behav. 2011;21(2):115-21.

Gano LB, Patel M, Rho JM. Ketogenic diets, mitochondria and neurological diseases. J Lipid Res. 2014;55(11):2211-28.

Philippi ST, Latterza AR, Cruz ATR, Ribeiro LC. Pirâmide alimentar adaptada: guia para escolha dos alimentos. Rev Nutr. 1999;12(1):65-80.

Liu Y-MC, Williams S, Basualdo-Hammond C, Stephens D, Curtis R. A prospective study: Growth and nutritional status of children treated with the ketogenic diet. JADA. 2003;103(6):707-12.

Murakami D, Lima PA. In: Silva APA, Nascimento AG, Zamberlan P. Manual de dietas e condutas nutricionais em pediatria. 2ª ed. São Paulo: Atheneu; 2014. p.2017-14.

Universidade Estadual de Campinas. Tabela Brasileira de Composição de Alimentos (Taco). 4ª ed.Campinas: Unicamp; 2011.

Freeman JM, Kelly MT, Freeman JB. The epilepsy diet treatment: An introduction to the ketogenic diet. New York: Demos; 1994.

Nonino-Borges CB, Bustamante VCT, Rabito EI, Inuzuka LM, Sakamoto AC, Marchini JS. Dieta cetogênica no tratamento de epilepsias farmacorresistentes. Rev Nutr. 2004;17(4):515-21. https://doi.org/10.1590/S1415-52732004000400011

McNally MA, Hartman AL. Ketone bodies in epilepsy. J Neurochemist. 2012;121(1):28-35. https://doi.org/10.1590/S1415-52732004000400011

Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003;290(7):912-20.

Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008;23(7):758-61.

Vining EPG, Pyzik P, McGrogan J, Hladky H, Anand A, Kriegler S, et al. Growth of children on the ketogenic diet. Dev Med Child Neurol. 2002;44(12):796-802.

Porta N, Vallée L, Boutry E, Fontaine M, Dessein AF, Joriot S, et al. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure. 2009;18(5):359-64.

Kinderen R, Lambrechts D, Postulart D, Kessels A, Hendriksen J, Aldenkamp A, et al. Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: Design of a randomized controlled trial. BMC Neurol. 2011;11(1):10.

Kossoff EH, Pyzik PL, McGrogan JR, Rubenstein JE. The impact of early versus late anticonvulsant reduction after ketogenic diet initiation. Epilepsy Behav. 2004;5(4):499-502.

Rocha GP, Batista BH, Nunes ML. Orientações ao pediatra sobre o manejo das drogas psicoativas e antiepilépticas. J Pediat. 2004;80(2):45-55.

Descargas

Publicado

2023-03-16

Cómo citar

Baldini PRUDENCIO, M. ., de Azevedo LIMA, P. ., Pruper de FREITAS, M. C. ., de Conti CARTOLANO, F. ., Kawamoto MURAKAMI, D. ., & Teixeira DAMASCENO, N. R. . (2023). Ketogenic food pyramid for patients with refractory epilepsy: From theory to clinical practice. Revista De Nutrição, 30(1). Recuperado a partir de https://puccampinas.emnuvens.com.br/nutricao/article/view/7834

Número

Sección

ARTIGOS ORIGINAIS